These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3159214)

  • 21. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
    Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL
    Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 23. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)].
    Bousser MG; Conard J; Lecrubier C; Bousser J
    Ann Med Interne (Paris); 1980; 131(2):87-90. PubMed ID: 7396326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated platelet reactivity in stable angina pectoris without significant coronary flow obstruction.
    Järemo P; Milovanovic M; Lindahl T; Richter A
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):129-30. PubMed ID: 18192803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical and surgical treatment of angina.
    Gazes PC
    J S C Med Assoc; 1981 Aug; 77(8):363-8. PubMed ID: 6795388
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lipid studies in myocardial infarct, angina pectoris and obliterating arteriosclerosis].
    Rechenberger J; Kröning G
    Z Gesamte Inn Med; 1973 Dec; 28(23):728-33. PubMed ID: 4362267
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
    Jakubowski JA; Payne CD; Li YG; Farid NA; Brandt JT; Small DS; Salazar DE; Winters KJ
    Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of corinfar on the dynamic function and various indices of glycolysis and glycogenolysis in the thrombocytes of patients with unstable stenocardia].
    Strizhak IG; Shanygina KI; Novikova NA; Chernysheva IN
    Ter Arkh; 1986; 58(5):73-7. PubMed ID: 3738797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The fatty acid pattern of phosphatides of serum and erythrocytes in patients with angina pectoris with and without coronarographically proven coronary sclerosis].
    Kunze D; Leuschner G
    Cor Vasa; 1972; 14(3):169-79. PubMed ID: 4637916
    [No Abstract]   [Full Text] [Related]  

  • 34. [Status and trends in the field of inhibitors of thrombocyte function].
    Glusa E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):575-9. PubMed ID: 6083929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood lipid profile in healthy subjects treated with ticlopidine.
    Violi F; Alessandri C; Iuliano L; Ghiselli A; Perrone A; Balsano F
    Atherosclerosis; 1985 Dec; 58(1-3):291-4. PubMed ID: 4091884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet factor 3 activity and platelet aggregation in patients submitted to coronarography.
    Renaud S; Gautheron P; Arbogast R; Dumont E
    Scand J Haematol; 1974; 12(2):85-92. PubMed ID: 4830612
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet survival in patients treated with ticlopidine following reconstructive arterial surgery.
    Davies JA; Tindall H; Paton RC; Menys VC; Doig RL; Kester RC; McNicol GP
    Thromb Res; 1982 Aug; 27(3):365-9. PubMed ID: 7135360
    [No Abstract]   [Full Text] [Related]  

  • 38. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ticlopidine: blood and liver involvement?].
    Biour M; Toussaint P; Duhamel G; Canuel C; Krulick M; Calmus Y
    Therapie; 1982; 37(2):222-4. PubMed ID: 7112492
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of lipid hyperperoxidation in disorders of structural organization of thrombocyte membranes].
    Almazov VA; Gurevich VS; Shatilina LV; Bykova NO; Bershadskiĭ BG
    Biull Eksp Biol Med; 1992 Sep; 114(9):265-7. PubMed ID: 1477351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.